Marijn M Speeckaert

InstitutionGhent University Hospital
AddressGhent
Belgium
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 25 Covid-19 publications, with a maximum of 3 publications in June 2020 and Spetember 2020 and April 2021 and May 2021 and June 2021
    All Publications
    Bar chart showing 116 publications over 16 distinct years, with a maximum of 13 publications in 2016 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Speeckaert MM, Delanghe JR. Contribution of Vitamin D-Binding Protein Polymorphism to Susceptibility and Outcome of COVID-19 Patients. J Nutr. 2021 08 07; 151(8):2498-2499. PMID: 34363485.
      Citations:    Fields:    Translation:Humans
    2. Speeckaert MM, Delanghe JR. The potential significance of vitamin D binding protein polymorphism in COVID-19. Int J Infect Dis. 2021 08; 109:90. PMID: 34174433.
      Citations:    Fields:    Translation:Humans
    3. Speeckaert R, Lambert J, Puig L, Speeckaert M, Lapeere H, De Schepper S, van Geel N. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? Drugs R D. 2021 Sep; 21(3):341-350. PMID: 34106430.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Delanghe JR, De Buyzere ML, Speeckaert MM. ABO Blood Groups and Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 06 01; 72(11):e917. PMID: 32986801.
      Citations:    Fields:    Translation:Humans
    5. Speeckaert MM, Speeckaert R, Delanghe JR. The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients. Eur J Pediatr. 2021 08; 180(8):2707-2708. PMID: 34027625.
      Citations:    Fields:    Translation:Humans
    6. Speeckaert MM, Delanghe JR. Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID- 19. Nutrition. 2021 May 18; 111347. PMID: 34167880.
      Citations:    Fields:    
    7. Speeckaert MM, Speeckaert R, Delanghe JR. Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19. Eur Respir J. 2021 05; 57(5). PMID: 33542051.
      Citations:    Fields:    Translation:Humans
    8. Speeckaert MM, Delanghe JR. Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients. Am J Clin Pathol. 2021 04 26; 155(5):766-767. PMID: 33399186.
      Citations: 1     Fields:    Translation:Humans
    9. Speeckaert MM, Speeckaert R, Delanghe JR. Vitamin D and Vitamin D binding protein: the inseparable duo in COVID-19. J Endocrinol Invest. 2021 Oct; 44(10):2323-2324. PMID: 33840080.
      Citations:    Fields:    Translation:Humans
    10. Speeckaert MM, Speeckaert R, Delanghe JR. Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link? Endocr Pract. 2021 06; 27(6):645. PMID: 33819636.
      Citations: 1     Fields:    Translation:Humans
    11. Speeckaert R, Lambert J, Puig L, Speeckaert M, Lapeere H, De Schepper S, van Geel N. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology". J Am Acad Dermatol. 2021 08; 85(2):e89-e90. PMID: 33744352.
      Citations:    Fields:    Translation:HumansPHPublic Health
    12. Speeckaert MM, Delanghe JR. A key role for vitamin D binding protein in COVID-19? Eur J Nutr. 2021 06; 60(4):2259-2260. PMID: 33585950.
      Citations:    Fields:    Translation:Humans
    13. Delanghe JR, De Buyzere ML, Speeckaert MM. Genetic Polymorphisms in the Host and COVID-19 Infection. Adv Exp Med Biol. 2021; 1318:109-118. PMID: 33973175.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Speeckaert MM, Delanghe JR. The influence of the genetic background of the host on vitamin D deficiency in children with COVID-19. Pediatr Pulmonol. 2021 05; 56(5):1259-1260. PMID: 33316149.
      Citations:    Fields:    Translation:Humans
    15. Speeckaert MM, De Buyzere ML, Delanghe JR. Vitamin D binding protein polymorphism and COVID-19. J Med Virol. 2021 02; 93(2):705-707. PMID: 32918506.
      Citations: 7     Fields:    Translation:Humans
    16. Speeckaert MM, Speeckaert R, Delanghe JR. Vitamin D binding protein in COVID-19. Clin Med (Lond). 2020 09; 20(5):e136-e137. PMID: 32934054.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    17. Speeckaert MM, Speeckaert R, Delanghe JR. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19. Mov Disord. 2020 09; 35(9):1497. PMID: 33400280.
      Citations:    Fields:    Translation:Humans
    18. Delanghe JR, De Buyzere ML, De Bruyne S, Van Criekinge W, Speeckaert MM. The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality. Ann Oncol. 2020 11; 31(11):1582-1584. PMID: 32835812.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    19. Delanghe JR, Speeckaert MM, De Buyzere ML. ACE polymorphism and COVID-19 outcome. Endocrine. 2020 10; 70(1):13-14. PMID: 32767193.
      Citations: 3     Fields:    Translation:CellsPHPublic Health
    20. Speeckaert MM, Speeckaert R, Delanghe JR. Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19. J Neuroradiol. 2020 Nov; 47(6):473-474. PMID: 32620231.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    21. Delanghe JR, Speeckaert MM, De Buyzere ML. COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clin Chem Lab Med. 2020 06 25; 58(7):1125-1126. PMID: 32286246.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    22. Delanghe JR, Speeckaert MM, De Buyzere ML. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19. Clin Chem Lab Med. 2020 06 25; 58(7):1129-1130. PMID: 32386189.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    23. Speeckaert MM, Delanghe JR. Association between low vitamin D and COVID-19: don't forget the vitamin D binding protein. Aging Clin Exp Res. 2020 07; 32(7):1207-1208. PMID: 32468505.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    24. Delanghe JR, De Buyzere ML, Speeckaert MM. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol. 2020 08; 27(12):1331-1332. PMID: 32460534.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    25. Delanghe JR, Speeckaert MM, De Buyzere ML. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Clin Chim Acta. 2020 06; 505:192-193. PMID: 32220422.
      Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
    Speeckaert's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (159)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _